Cardior Pharmaceuticals picks up $76m Series B
Cardior Pharmaceuticals, a developer of non-coding RNA-based therapeutics for patients with cardiac diseases, has raised $76 million in Series B financing.
Cardior Pharmaceuticals, a developer of non-coding RNA-based therapeutics for patients with cardiac diseases, has raised $76 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination